Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) E2F4 Antibodies:
anti-Human E2F4 Antibodies:
anti-Rat (Rattus) E2F4 Antibodies:
Go to our pre-filtered search.
Human Monoclonal E2F4 Primary Antibody for WB - ABIN394384
van Amerongen, Diehl, Novoyatleva, Patra, Engel: E2F4 is required for cardiomyocyte proliferation. in Cardiovascular research 2010
Show all 5 references for ABIN394384
Mouse (Murine) Polyclonal E2F4 Primary Antibody for EIA, IP - ABIN492950
Iglesias, Murga, Laresgoiti, Skoudy, Bernales, Fullaondo, Moreno, Lloreta, Field, Real, Zubiaga: Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice. in The Journal of clinical investigation 2004
Show all 4 references for ABIN492950
Human Monoclonal E2F4 Primary Antibody for IF, IHC (p) - ABIN115206
Ikeda, Jakoi, Nevins: A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. in Proceedings of the National Academy of Sciences of the United States of America 1996
Show all 3 references for ABIN115206
Chicken Polyclonal E2F4 Primary Antibody for IHC, WB - ABIN2777218
DuPree, Mazumder, Almasan: Genotoxic stress induces expression of E2F4, leading to its association with p130 in prostate carcinoma cells. in Cancer research 2004
Following stress exposure, E2F4-p130 complexes are lost rapidly along with the presence of E2F4 at E2F (show E2F1 Antibodies)-containing B-Myb (show MYBL2 Antibodies) promoter sites.
E2F4 is part of a transcriptional repressor complex comprising p130 and HDAC1 (show HDAC1 Antibodies) in cardiac myocytes. Relief from E2F4-dependent gene silencing induces the expression of pro-apoptotic genes.
In terminally differentiated cells, common KDM5A (show KDM5A Antibodies) and E2F4 gene targets were bound by the pRB (show PGR Antibodies)-related protein p130, a DREAM complex component.
We report here a new cellular function of p27 (show CDKN1B Antibodies) as a transcriptional regulator in association with p130/E2F4 complexes that could be relevant for tumorigenesis.
Induction of Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling in mouse mesenchymal stem cells is associated with activation of the p130 and E2f4 and formation of the p130/Gsk3beta (show GSK3b Antibodies)/beta-catenin (show CTNNB1 Antibodies) complex.
E2F4 plays an important role in enabling osteoblast progenitors to exit the cell cycle and subsequently differentiate thereby contributing to the commitment of these cells to the bone lineage.
Our data indicate that E2F4 is required for cardiomyocyte proliferation and suggest a function for E2F4 in mitosis
E2F4 controls cell cycle exit through different mechanisms.
interactions are regulated by G1 cyclin/cyclin (show PCNA Antibodies)-dependent kinase (show CDK1 Antibodies)-coordinated phosphorylation of endogenous pocket proteins
E2F4 has a role in adipogenesis independent of its cell cycle regulatory activity
PHF8 (show PHF8 Antibodies) reduces the H3K9me2 level at the E2F4 transcriptional start site, demonstrating a direct function of PHF8 (show PHF8 Antibodies) in endothelial E2F4 gene regulation
cell cycle-dependent transcription of the TRAIP (show TRAIP Antibodies) gene by E2F1 (show E2F1 Antibodies), E2F2 (show E2F2 Antibodies), and E2F4 and rapid protein degradation leads to cell cycle-dependent expression with a maximum in G2/M
Authors show that BRCA1 and RAD17 (show RAD17 Antibodies) genes, whose derived proteins play a pivotal role in DNA damage repair, are transcriptional targets of gain-of-function mutant p53 (show TP53 Antibodies) proteins.
Data suggest that aberrant cell cycle activation in Ewing sarcoma is due to the de-repression of transcription factor E2F targets of transcriptional induction and physical recruitment of E2F3 by fusion protein EWS (show EWSR1 Antibodies)-FLI1 (show FLI1 Antibodies) replacing E2F4 on their promoters.
The inverse immunohistochemical relationship between E2F1 (show E2F1 Antibodies) and E2F4 indicates a possible mechanistic interlink in colorectal cancer.
E2F4 promoter occupancy is globally associated with p53 (show TP53 Antibodies)-repression targets, but not with p53 (show TP53 Antibodies) activation targets.
cancer-associated E2F4 mutations enhance the capacity of colorectal cancer cells to grow without anchorage, thereby contributing to tumor progression.
Analysis data from a panel of cell cycle transcription factors (E2F1, E2F4, E2F6, and GABPA) finds that a set of core cell cycle genes regulated in both U2OS and HeLa cells are bound by multiple cell cycle transcription factors.
Short alleles (<13 repeats) of (AGC (show ACAN Antibodies))n in E2F4 were less frequent in women with breast cancer than in the control sample.
the loss of CDH1 (show CDH1 Antibodies)/E2F4 may be associated with worse clinical and pathological findings in mammary ductal carcinoma.
The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein binds to all three of the tumor suppressor proteins pRB, p107 and p130, but with higher affinity to the last two. It plays an important role in the suppression of proliferation-associated genes, and its gene mutation and increased expression may be associated with human cancer.
E2F transcription factor 4, p107/p130-binding
, transcription factor E2F4
, p107/p130-binding protein
, E2F transcription factor 4